Silvia Damian
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
UpSMART: five years of digital innovation in cancer clinical research-achievements, challenges, and recommendations.
Journal: Frontiers in digital health
Published: September 18, 2025
Validating HER2 copy number variation assessment by NGS: A comparative analysis with immunohistochemistry and in situ hybridization.
Journal: Tumori
Published: July 09, 2025
Real-World Outcomes of Molecular Tumor Board Treatment Recommendations.
Journal: JCO precision oncology
Published: June 11, 2025
ICIs Exceptional Long Response in TNBC: Addressing the Issue of Optimal ICIs Duration. Two Cases and Review of the Literature.
Journal: Cancer reports (Hoboken, N.J.)
Published: April 26, 2025
Publisher Correction: Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial.
Journal: Nature medicine
Published: May 24, 2024
PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trials.
Journal: Tumori
Published: April 27, 2024
Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined with Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 01, 2024
Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade.
Journal: Scientific reports
Published: November 06, 2023
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care.
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care.
Journal: JCO precision oncology
Published: July 24, 2023
Last Updated: 09/26/2026